您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (12): 14-19.doi: 10.6040/j.issn.1671-7554.0.2016.040

• 基础医学 • 上一篇    下一篇

miR-916a调控SOCS6促进HBx-HepG2细胞生长

余桂芳,陈树娣,陈雪竹,侯开连,梁敏   

  1. 广州医科大学附属第五医院肿瘤科, 广东 广州 510700
  • 收稿日期:2016-01-12 出版日期:2016-12-10 发布日期:2016-12-10
  • 通讯作者: 余桂芳. E-mail:guifangyu1023@sina.com E-mail:guifangyu1023@sina.com
  • 基金资助:
    广东省科技计划(20130319c)

miR-196a promotes cell growth of HBx-HepG2 via targeting SOCS6

YU Guifang, CHEN Shudi, CHEN Xuezhu, HOU Kailian, LIANG Min   

  1. Department of Oncology, Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, Guangdong, China
  • Received:2016-01-12 Online:2016-12-10 Published:2016-12-10

摘要: 目的 探讨HBx-HepG2细胞中miR-196a对细胞因子信号抑制物6(SOCS6)表达的调控作用以及对细胞生长的促进作用,并研究其潜在的分子作用机制。 方法 利用qRT-PCR检测miR-196a以及SOCS6 mRNA的表达水平;Western blotting检测SOCS6蛋白表达水平;CCK-8和集落形成实验检测细胞的生长;采用双荧光素酶报告实验验证miR-196a的靶基因。 结果 与正常人肝细胞(L02)相比, miR-196a在HBx-HepG2细胞中过量表达(P<0.05)。miR-196a过表达可促进HBx-HepG2细胞生长;miR-196a表达下调可抑制HBx-HepG2细胞生长,与对照组相比差异具有统计学意义(P<0.05)。与正常人肝细胞(L02)相比, SOCS6 mRNA在HBx-HepG2细胞中表达下调(P<0.05);miR-196a可以通过作用于SOCS6的3'UTR区负向调控其表达, 并且SOCS6 的过表达可以抑制HBx-HepG2细胞的生长。 结论 miR-196a可以通过靶向负调控SOCS6基因进而促进HBx-HepG2细胞的生长。

关键词: 细胞生长, 细胞因子信号抑制物6, miR-196a, HBx-HepG2细胞

Abstract: Objective To explore the effect of miR-196a on cell growth in HBx-HepG2 cells, and to explore its underlying molecular mechanism. Methods The expressions of miR-196a and SOCS6 mRNA were detected with QRT-PCR, and the protein expression of SOCS6 was determined with Western blotting. The cell growth in HBx-HepG2 cells was evaluated with CCK-8 and colony formation assay. The target gene of miR-196a was validated with dual luciferase reporter experiment. Results The expression of miR-196a was significantly higher in HBx-HepG2 cells than in normal human liver cells(L02)(P<0.05). Over-expression of miR-196a enhanced cell growth in HBx-HepG2 cells(P<0.05), while knockdown of miR-196a suppressed cell growth(P<0.05). SOCS6 was downregulated in HBx-HepG2 cells compared with L02 cells(P<0.05), and miR-196a downregulated the expression of SOCS6 via targeting 3'UTR of SOCS6. Overexpression SOCS6 in HBx-HepG2 cells promoted cell growth. Conclusion miR-196a enhances cell growth via down-regulation of SOCS6 in HBx-HepG2 cells.

Key words: miR-196a, HBx-HepG2 cells, Suppressor of cytokine signaling 6, Cell growth

中图分类号: 

  • R574
[1] Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: role of microRNA[J]. World J Gastroenterol, 2013, 19(33): 5439-5445.
[2] Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells[J]. Liver Cancer, 2014, 3(2): 71-84.
[3] Sidhu K, Kapoor NR, Pandey V, et al. The “Macro” world of microRNAs in hepatocellular carcinoma[J]. Front Oncol, 2015, 5: 68. doi: 10.3389/fonc.2015.00068.
[4] Xu Y, Li L, Xiang X, et al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis[J]. Gene, 2013, 527(2): 584-593.
[5] Hao Y, Wang J, Zhao L. The effect and mechanism of miR196a in HepG2 cell[J]. Biomed Pharmacother, 2015, 72: 1-5. doi: 10.1016/j.biopha.2014.10.032.
[6] Li XD, Li ZG, Song XX, et al. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis[J]. Pathology, 2010, 42(7): 669-673.
[7] Kokabi N, Xing M, Jr RD, et al. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study[J]. Future Oncol, 2016, 12(2): 183-198.
[8] Buendia MA, Neuveut C. Hepatocellular carcinoma[J]. Cold Spring Harb Perspect Med, 2015, 5(2): a021444. doi: 10.1101/cshperspect.a021444.
[9] Geng M, Xin X, Bi LQ, et al. Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis[J]. World J Gastroenterol, 2015, 21(38): 10732-10738.
[10] 余桂芳, 严跃红, 王瑞鑫, 等. 慢病毒介导HBV X基因稳定表达HepG2细胞系的建立[J]. 世界华人消化杂志, 2012, 20(8): 638-643.
[11] Tsai MM, Wang CS, Tsai CY, et al. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer[J]. Cancer Lett, 2014, 351(2): 222-231.
[12] Huang F, Tang J, Zhuang X, et al. miR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha[J]. PLoS One, 2014, 9(2): e87897. doi: 10.1371/journal.pone.0087897.
[13] Han Q, Zhou C, Liu F, et al. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer[J]. Oncol Rep, 2015, 34(2): 877-883.
[14] Kabir NN, Sun J, Ronnstrand L, et al. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling[J]. Tumour Biol, 2014, 35(11): 10581-10589.
[15] Wu Q, Luo G, Yang Z, et al. miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells[J]. FEBS Lett, 2014, 588(12): 2055-2062.
[16] Wu K, Hu G, He X, et al. MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer[J]. Pathol Oncol Res, 2013, 19(4): 739-748.
[17] Li ZB, Li ZZ, Li L, et al. miR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma(HCC)cells[J]. Eur Rev Med Pharmacol Sci, 2015, 19(17): 3208-3217.
[18] Qiu X, Zheng J, Guo X, et al. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis[J]. Mol Cell Biochem, 2013, 378(1-2): 99-106.
[19] Kazi JU, Sun J, Phung B, et al. Suppressor of cytokine signaling 6(SOCS6)negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3[J]. J Biol Chem, 2012, 287(43): 36509-36517.
[1] 谭琦,李娜,陶运明,唐浩,吴忠仕. 载血管内皮生长因子层层自组装提高异种去细胞血管生物相容性[J]. 山东大学学报(医学版), 2017, 55(5): 23-30.
[2] 宗兆运,李霞,韩振龙,王显腾,郭春,张利宁,石永玉. 肿瘤相关巨噬细胞对肝癌细胞c-Met分子表达的影响[J]. 山东大学学报(医学版), 2016, 54(3): 14-18.
[3] 吕树卿, 尉蔚, 张灿灿, 田永杰. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报(医学版), 2015, 53(7): 1-7.
[4] 付庆元, 戴桂强, 张松, 安洪春, 梁世民. 西洋参茎叶皂苷对脑梗死大鼠ET-1、VEGF及脑梗死面积的影响[J]. 山东大学学报(医学版), 2014, 52(9): 30-33.
[5] 李静, 徐彤彤, 余帆. 原发性高血压患者血清IMD、CysC、FGF23与动脉粥样硬化的关系[J]. 山东大学学报(医学版), 2014, 52(10): 49-54.
[6] 徐荣建,王法刚,党伟,曹永倩,林莉,韦浩,赵君,国丽. 激光治疗对婴幼儿皮肤血管瘤患者血浆VEGF及bFGF表达的影响[J]. 山东大学学报(医学版), 2013, 51(4): 96-99.
[7] 韩艳鑫,丛雅琴,王志敏. 骨髓增生异常综合征患者骨髓间充质干细胞的免疫抑制作用[J]. 山东大学学报(医学版), 2012, 50(6): 97-.
[8] 孟又胜,王秀问,王亚伟,田甜甜. siRNA干扰沉默bFGF基因对肺腺癌A549增殖和凋亡的影响[J]. 山东大学学报(医学版), 2012, 50(3): 50-54.
[9] 朱俊德1, 2,王贵学2,余彦1,余资江1,肖朝伦1,王玉林1. 碱性成纤维细胞生长因子对动脉粥样硬化模型大鼠脑顶叶皮质与大脑中动脉的影响[J]. 山东大学学报(医学版), 2012, 50(11): 23-.
[10] 纪孝伟1,2,毕建忠1. 卒中后抑郁大鼠脑内FGF-2表达的研究[J]. 山东大学学报(医学版), 2011, 49(9): 30-.
[11] 刘滨,刘威,范海涛,侯现增,贾践博,许尚臣,庞琦. HGF及其受体C-Met 和VEGF与星形细胞肿瘤恶性程度及其血管生成之间的关系[J]. 山东大学学报(医学版), 2011, 49(2): 109-.
[12] 刘金峰1,张楠2,徐超3,李哲2,刘杰2,孙玉萍2. HIF-1α与HGF在非小细胞肺癌中的共表达及其与淋巴管生成的关系[J]. 山东大学学报(医学版), 2011, 49(11): 112-.
[13] 单菲1,姜笃银1,宗宪磊1,付小兵2,刘军莉3,赵敬杰3. KGF在成纤维细胞促进表皮细胞增殖中的作用[J]. 山东大学学报(医学版), 2010, 48(4): 18-22.
[14] 杨晓冉1,李运1,巩磊1,肖瑛2,郭海燕1. bFGF在持续高眼压下对兔视网膜神经节细胞的保护作用[J]. 山东大学学报(医学版), 2010, 48(4): 74-.
[15] 王婧男1,张楠2,赵建强2,高爱琴3,林文俐3,孙玉萍2. 乳腺癌中HGF及其受体c-met的表达与淋巴管生成及淋巴道转移的关系[J]. 山东大学学报(医学版), 2010, 48(3): 90-93.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!